Treating lymphoma or leukemia in a patient comprises modulating the level of an expression product of a gene selected from PI3KR1, GNAS, NESP5, JAK1, neurogranin, HIPK1, or Nrf2

Finn Skou Pedersen (Inventor), Annette Balle Sørensen (Inventor), Anne Ahlmann Nielsen (Inventor), Javier Martin Hernandez (Inventor), Helle Moving (Inventor)

Research output: Patent

Original languageEnglish
IPCA61K-039/395
Patent numberUS2007098728-A1
Filing date03/05/2007
CountryUnited States
Publication statusPublished - 2007
Externally publishedYes

Cite this